Hyperphosphataemia: Treatment Options - Malberti, Fabio (Drugs (New York, N.Y.), 2013)
Keywords: Biological and medical sciences; Calcification; Chelating Agents - adverse effects; Chelating Agents - therapeutic use; General and cellular metabolism. Vitamins; Hemodialysis; Humans; Hyperphosphatemia - complications; Hyperphosphatemia - diet therapy; Hyperphosphatemia - drug therapy; Hyperphosphatemia - etiology; Hypocalcemia; Internal Medicine; Kidney Failure, Chronic - complications; Kidney Failure, Chronic - diet therapy; Kidney Failure, Chronic - drug therapy; Medical sciences; Medicine; Medicine & Public Health; Mortality; Patients; Pharmacology. Drug treatments; Pharmacology/Toxicology; Pharmacotherapy; Phosphorus; Review Article; Chronic Kidney Disease Patient; Chronic Kidney Disease; Chronic Kidney Disease Stage; Phosphate Binder; Vascular Calcification; Human; Phosphates; Hydroelectrolytic balance disorder; Oral administration; Phosphorus; Review; Inorganic element; Metabolic disorder; Treatment; Lanthanum carbonate; Chelating agent; Hyperphosphatemia; Sevelamer